cycloheximide has been researched along with santalol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agarwal, C; Agarwal, R; Dwivedi, C; Guan, X; Kaur, M; Singh, RP | 1 |
1 other study(ies) available for cycloheximide and santalol
Article | Year |
---|---|
Skin cancer chemopreventive agent, {alpha}-santalol, induces apoptotic death of human epidermoid carcinoma A431 cells via caspase activation together with dissipation of mitochondrial membrane potential and cytochrome c release.
Topics: Apoptosis; Carcinoma; Caspase Inhibitors; Caspases; Cell Proliferation; Cycloheximide; Cytochromes c; Enzyme Inhibitors; Humans; Intracellular Membranes; Membrane Potentials; Mitochondria; Plant Oils; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Polycyclic Sesquiterpenes; Sesquiterpenes; Skin Neoplasms; Tumor Cells, Cultured | 2005 |